Guangdong Zhongsheng Ruichuang Biotechnology Co., Ltd. announced that it has received funding of CNY 370 million on December 30, 2022. The investment was coled by the new investors Shenzhen Qianhai Xinyi Yide Fund Management Co., Ltd. and Qingchi Capital. The other investors were Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SZSE:002317), Guangdong Boguan Yuanchuang Biotechnology Research Center (Limited Partnership), Wanlian Guangsheng Investment Co., Ltd. and Guangzhou Guoju Venture Capital Co., Ltd.